Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain Dec 13, 2021 7:00am EST
Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team Nov 11, 2021 7:00am EST
Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021 Nov 08, 2021 7:00am EST
Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients Sep 30, 2021 7:00am EDT
Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit Sep 17, 2021 7:00am EDT
Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Sep 09, 2021 7:00am EDT
Trevena Announces Two OLINVYK® Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY® 2021 Aug 30, 2021 7:00am EDT
